Advances in COVID-19 mRNA vaccine development
E Fang, X Liu, M Li, Z Zhang, L Song, B Zhu… - Signal transduction and …, 2022 - nature.com
To date, the coronavirus disease 2019 (COVID-19) caused by severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2) has determined 399,600,607 cases and 5,757,562 …
syndrome coronavirus 2 (SARS-CoV-2) has determined 399,600,607 cases and 5,757,562 …
[HTML][HTML] mRNA vaccines for COVID-19: what, why and how
JW Park, PNP Lagniton, Y Liu… - International journal of …, 2021 - ncbi.nlm.nih.gov
Abstract The Coronavirus disease-19 (COVID-19) pandemic, caused by severe acute
respiratory syndrome coronavirus-2 (SARS-CoV-2), has impacted human lives in the most …
respiratory syndrome coronavirus-2 (SARS-CoV-2), has impacted human lives in the most …
mRNA vaccines against SARS-CoV-2: Advantages and caveats
M Echaide, L Chocarro de Erauso… - International Journal of …, 2023 - mdpi.com
The application of BNT162b2 and mRNA-1273 vaccines against SARS-CoV-2 infection has
constituted a determinant resource to control the COVID-19 pandemic. Since the beginning …
constituted a determinant resource to control the COVID-19 pandemic. Since the beginning …
COVID-19 mRNA vaccines: Platforms and current developments
GT Szabó, AJ Mahiny, I Vlatkovic - Molecular Therapy, 2022 - cell.com
Since the first successful application of messenger ribonucleic acid (mRNA) as a vaccine
agent in a preclinical study nearly 30 years ago, numerous advances have been made in …
agent in a preclinical study nearly 30 years ago, numerous advances have been made in …
The development of mRNA vaccines for infectious diseases: recent updates
Nitika, J Wei, AM Hui - Infection and drug resistance, 2021 - Taylor & Francis
Abstract mRNA-based technologies have been of interest for the past few years to be used
for therapeutics. Several mRNA vaccines for various diseases have been in preclinical and …
for therapeutics. Several mRNA vaccines for various diseases have been in preclinical and …
mRNA vaccines
Q Huang, J Zeng, JC Yan - J Genet Genomics, 2021 - cell.com
The Nobel Committee awarded the 2023 Prize for Physiology and Medicine to Drs. Katalin
Karikó and Drew Weissman “for their discoveries concerning nucleoside base modifications …
Karikó and Drew Weissman “for their discoveries concerning nucleoside base modifications …
The importance of RNA-based vaccines in the fight against COVID-19: an overview
BAS Machado, KVS Hodel, LMS Fonseca… - Vaccines, 2021 - mdpi.com
In recent years, vaccine development using ribonucleic acid (RNA) has become the most
promising and studied approach to produce safe and effective new vaccines, not only for …
promising and studied approach to produce safe and effective new vaccines, not only for …
mRNA-based vaccine for COVID-19: they are new but not unknown!
mRNA vaccines take advantage of the mechanism that our cells use to produce proteins.
Our cells produce proteins based on the knowledge contained in our DNA; each gene …
Our cells produce proteins based on the knowledge contained in our DNA; each gene …
An insight overview on COVID-19 mRNA vaccines: advantageous, pharmacology, mechanism of action, and prospective considerations
The worldwide spread of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
has urged scientists to present some novel vaccine platforms during this pandemic to …
has urged scientists to present some novel vaccine platforms during this pandemic to …
mRNA-based vaccines and therapeutics for COVID-19 and future pandemics
An unheard mobilization of resources to find SARS-CoV-2 vaccines and therapies has been
sparked by the COVID-19 pandemic. Two years ago, COVID-19's launch propelled mRNA …
sparked by the COVID-19 pandemic. Two years ago, COVID-19's launch propelled mRNA …